Peter Allen

Peter Allen is a Research Officer 1-4 at the Garvan Institute for Medical Research, where he is investigating the role of genetic variants in interstitial lung diseases (ILDs). During his PhD at the University of Alabama at Birmingham, he analyzed the methylomes of Scleroderma and Systemic Lupus Erythematosus (SLE) to understand their involvement in disease severity in the Southeasten US, comparing African American and European American methylation profiles. His study revealed that the interferon methylation signature, previously thought to be specific to African American SLE patients, was also present in European Americans with Lupus Nephritis, suggesting a more severe SLE phenotype in African American SLE patients on average when compared to European American SLE patients.

Peter's computational background focuses on developing statistical models to understand disease. He plans to utilize computational modelling to identify diagnostic and prognostic markers within ILDs such as idiopathic pulmonary fibrosis and sarcoidosis using single cell genomics.

For more information, visit https://petercallen.github.io/.